VIRBAC Aktie

 

Das Instrument V16 FR0000031577 VIRBAC SA EO 1,25 EQUITY wird ex Dividende/Zinsen gehandelt am 24.06.2025 The instrument V16 FR0000031577 VIRBAC SA EO 1,25 EQUITY has its ex-dividend/interest day on 24.06.2025...

Das Instrument V16 FR0000031577 VIRBAC SA EO 1,25 EQUITY wird cum Dividende/Zinsen gehandelt am 23.06.2025 und ex Dividende/Zinsen am 24.06.2025 The instrument V16 FR0000031577 VIRBAC SA EO 1,25 EQUITY has its pre-dividend/interest day on 23.06.2025 and its ex-dividend/interest day on 24.06.2025...

 Virbac announces the appointment of Paul Martingell as the chief executive officer of the Virbac group, effective September 1, 2025....

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS...

The Group released and filed its 2024 Annual Report with the French “Autorité des marchés financiers”, at the ESEF Format....

In the first quarter of 2025, revenue recorded solid growth of +4.9% at constant exchange rates and scope...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS...

Public release of Virbac Consolidated Accounts at 31 December 2024....

1variance at constant exchange rates and scope corresponds to the organic growth of sales, excluding exchange rate variations, by calculating the indicator for the financial year in question and the indicator for the previous financial year on the basis of identical exchange rates (the exchange rate used is the one from the previous financial year), and excluding change in scope, by calculating the indicator for the financial year in question on the basis of the scope of consolidation for the previous financial year2current operating income, before depreciation of assets arising from acquisitions, reflects current income adjusted for the impact of allowances for depreciation of intangible assets resulting from acquisition transactions3net debt corresponds to current (€57.9 million) and non-current (€222.1 million) financial liabilities as well as a lease obligation related to the application of IFRS 16 (current €11,5 millions € and non-current 26,6 millions €), less the cash and cash equivalents...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS...

DECLARATION D'ACTIONS ET DE DROITS DE VOTE...

Combating stress to keep felines in loving homes WESTLAKE, Texas, Jan. 23, 2025 /PRNewswire/ -- Among cats, 98% show signs of stress, often through behaviors such as running away, hiding, vocalizing, scratching furniture or inappropriate elimination.1,2 To address these common......

Strong annual revenue growth of +13.6% supported by dynamic organic growth (+7.5%) and the strategic contribution of our acquisitions (+6.1%)...

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS...

Ursolic acid shown to help improve dogs' functional performance WESTLAKE, Texas, Jan. 7, 2025 /PRNewswire/ -- Virbac, a global leader in animal health, has collaborated with Emmyon, Inc., a biotechnology company specializing in skeletal muscle biology, to introduce URSOLYX™ Soft Chews.......

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS...

On December 2, we finalized the acquisition of Turkish company Mopsan, specialized in the distribution of petfood and companion animal health products....

DECLARATION OF THE NUMBER OF SHARES AND VOTING RIGHTS...

Virbac falls as Q3 marks 'weakest quarter of the year'...